2,2-Dimethylpropyl 3-methylbutanoate | 5340-68-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2,2-Dimethylpropyl 3-methylbutanoate
• CAS: 5340-68-1
• 化学式: C₁₀H₂₀O₂
• 分子量: 172.26
• InChiKey: KJHHLUGEJAXBEI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
  申请人：CHO Dong-Gyu

  公开号：US20100004440A1

  公开（公告）日：2010-01-07

  The present invention relates to an acyclic nucleoside phosphonate derivative which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof.

  本发明涉及一种无环核苷酸膦酸酯衍生物，其可用作抗病毒剂（特别是针对乙型肝炎病毒），药学上可接受的盐，立体异构体以及其制备方法。
• SUBSTITUTED IMIDAZOLES
  申请人：Chubb Nathan Anthony Logan

  公开号：US20090312326A1

  公开（公告）日：2009-12-17

  This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.

  本发明涉及一系列α取代的2-苄基取代咪唑化合物及其药学上可接受的盐和溶剂化物，涉及包含这些化合物的组合物、它们的合成过程以及它们用作寄生虫药物的用途。
• Substituted imidazoles and their use as pesticides
  申请人：Pfizer Limited

  公开号：EP2423199A1

  公开（公告）日：2012-02-29

  This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.

  本发明涉及一系列α-取代的 2-苄基取代咪唑化合物及其药学上可接受的盐和溶液，涉及包含此类化合物的组合物、其合成工艺及其作为杀寄生虫剂的用途。
• Novel inhibitors of Hepatitis C virus NS3 protease
  申请人：Bogen L. Stephane

  公开号：US20070142301A1

  公开（公告）日：2007-06-21

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
• US7157448B2
  申请人：——

  公开号：US7157448B2

  公开（公告）日：2007-01-02